FDA issues hold on much-debated Avandia study
Wednesday, July 21, 2010 - 11:35
in Health & Medicine
By 2010-07-21T16:30:27Z WASHINGTON (AP) -- Federal health officials say new patients should not be enrolled in a study of GlaxoSmithKline's controversial diabetes pill Avandia, after experts last week said the drug increases heart risks....